Cargando…

Efficacy and safety of CYP2C19 genotype in stroke or transient ischemic attack patients treated with clopidogrel monotherapy or clopidogrel plus aspirin: Protocol for a systemic review and meta-analysis

BACKGROUND: The relationship of CYP2C19 genotype and clinical efficacy in stroke or transient ischemic attack (TIA) patients treated with clopidogrel monotherapy or clopidogrel plus aspirin remains unknown. We thus aim to conduct a meta-analysis to appraise evidence on the association of CYP2C19 gen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yao, Jia-Chen, Cui, Min, Pan, Mang-Mang, Gu, Zhi-Chun, Li, Wen-Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023652/ https://www.ncbi.nlm.nih.gov/pubmed/29901608 http://dx.doi.org/10.1097/MD.0000000000011060

Ejemplares similares

Treatment Effect of Clopidogrel Plus Aspirin Within 12 Hours of Acute Minor Stroke or Transient Ischemic Attack
por: Li, Zixiao, et al.
Publicado: (2016)

Cost‐Effectiveness of Clopidogrel‐Aspirin Versus Aspirin Alone for Acute Transient Ischemic Attack and Minor Stroke
por: Pan, Yuesong, et al.
Publicado: (2014)

Efficacy and safety of clopidogrel and/or aspirin for ischemic stroke/transient ischemic attack: An overview of systematic reviews and meta-analysis
por: Yang, Youwen, et al.
Publicado: (2021)

Comparison of administration of clopidogrel with aspirin versus aspirin alone in prevention of secondary stroke after transient ischemic attack
por: Khazaei, Mojtaba, et al.
Publicado: (2019)

Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack: systematic review and meta-analysis
por: Hao, Qiukui, et al.
Publicado: (2018)

Comparative effect of clopidogrel plus aspirin and aspirin monotherapy on hematological parameters using propensity score matching
por: Hayasaka, Masatoshi, et al.
Publicado: (2013)

Ticagrelor vs Clopidogrel in addition to Aspirin in minor ischemic stroke/ transient ischemic attack—Protocol for a systematic review and network meta-analysis
por: Zitikyte, Gabriele, et al.
Publicado: (2021)

A systematic review and meta-analysis of published randomized controlled trials of combination of clopidogrel and aspirin in transient ischemic attack or minor stroke
por: Zhou, Xingjian, et al.
Publicado: (2017)

Combined impact of body mass index and glycemic control on the efficacy of clopidogrel-aspirin therapy in patients with minor stroke or transient ischemic attack
por: Chen, Zimo, et al.
Publicado: (2020)

Aspirin and Clopidogrel Resistance
por: Sztriha, Laszlo K., et al.
Publicado: (2004)

Ticagrelor plus aspirin versus clopidogrel plus aspirin for platelet reactivity in patients with minor stroke or transient ischaemic attack: open label, blinded endpoint, randomised controlled phase II trial
por: Wang, Yilong, et al.
Publicado: (2019)

Benefits and Risks of Clopidogrel vs. Aspirin Monotherapy after Recent Ischemic Stroke: A Systematic Review and Meta-Analysis
por: Paciaroni, Maurizio, et al.
Publicado: (2019)

Impact of body mass index on efficacy and safety of ticagrelor versus clopidogrel in patients with minor stroke or transient ischemic attack
por: Zhang, Jia, et al.
Publicado: (2023)

Effectiveness and safety of high dose clopidogrel plus aspirin in ischemic stroke patients with the single CYP2C19 loss-of-function allele: a randomized trial
por: Wu, Hongliang, et al.
Publicado: (2020)

Personalized antiplatelet therapy guided by clopidogrel pharmacogenomics in acute ischemic stroke and transient ischemic attack: A prospective, randomized controlled trial
por: Zhang, Xiaoguang, et al.
Publicado: (2023)

Economic Evaluation of Ticagrelor Plus Aspirin Versus Aspirin Alone for Acute Ischemic Stroke and Transient Ischemic Attack
por: Chen, Jigang, et al.
Publicado: (2022)

Clopidogrel and Aspirin versus Aspirin Alone for Stroke Prevention: A Meta-Analysis
por: Tan, Shuai, et al.
Publicado: (2015)

Aspirin Versus Clopidogrel Monotherapy for the Secondary Prevention of Recurrent Cerebrovascular Attack Following Previous Ischemic Stroke in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
por: Qin, Zu-Ye, et al.
Publicado: (2020)

Cerebral microbleeds in patients with ischemic cerebrovascular disease taking aspirin or clopidogrel
por: Ge, Lihong, et al.
Publicado: (2019)

Variants in clopidogrel-relevant genes and early neurological deterioration in ischemic stroke patients receiving clopidogrel
por: Yi, Xingyang, et al.
Publicado: (2020)

Clopidogrel Plus Aspirin in Patients With Different Types of Single Small Subcortical Infarction
por: Wang, Guangyao, et al.
Publicado: (2021)

The Efficacy and Adverse Reaction of Bleeding of Clopidogrel plus Aspirin as Compared to Aspirin Alone after Stroke or TIA: A Systematic Review
por: Huang, Yan, et al.
Publicado: (2013)

Measurement of Platelet Function in an Experimental Stroke Model With Aspirin and Clopidogrel Treatment
por: Lieschke, Franziska, et al.
Publicado: (2020)

Dual Antiplatelet Therapy with Clopidogrel and Aspirin Versus Aspirin Monotherapy in Patients Undergoing Coronary Artery Bypass Graft Surgery
por: Qu, Jianyu, et al.
Publicado: (2021)

Aspirin and clopidogrel resistance: methodological challenges and opportunities
por: Gasparyan, Armen Yuri
Publicado: (2010)

Aspirin/clopidogrel: Lack of efficacy: case report
Publicado: (2020)

Ticagrelor plus aspirin in patients with minor ischemic stroke and transient ischemic attack: a network meta-analysis
por: Li, Mingxia, et al.
Publicado: (2023)

A Combination of Aspirin and Clopidogrel Predict More Favorable Dynamics of Platelet Reactivity versus Clopidogrel Alone in the Acute Phase of Minor Stroke
por: Wiśniewski, Adam, et al.
Publicado: (2021)

Efficacy and safety of low dose aspirin plus clopidogrel in the treatment of elderly patients with symptomatic intracranial artery stenosis
por: Song, Hai-xia, et al.
Publicado: (2023)

Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance - The BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy
por: Neubauer, Horst, et al.
Publicado: (2011)

Efficacy and safety of clopidogrel versus aspirin monotherapy for secondary prevention in patients with coronary artery disease: a meta-analysis
por: Liu, Di, et al.
Publicado: (2023)

Frequency of microembolic signals in patients with acute ischemic stroke in middle cerebral artery territory treated with aspirin or clopidogrel
por: Hashemilar, Mazyar, et al.
Publicado: (2011)

Aspirin and Clopidogrel Resistance in Indian Patients with Ischemic Stroke and its Associations with Gene Polymorphisms: A Pilot Study
por: Patel, Samir, et al.
Publicado: (2019)

Is clopidogrel superior to aspirin in secondary prevention of vascular disease?
por: Algra, Ale, et al.
Publicado: (2000)

Mapping the antiplatelet effects of clopidogrel and aspirin by modified thromboelastography
por: Hemlata,, et al.
Publicado: (2013)

Is clopidogrel better than aspirin following breakthrough strokes while on aspirin? A retrospective cohort study
por: Lee, Meng, et al.
Publicado: (2014)

Comment on “Association between CYP2C19 and ABCB1 polymorphisms and clopidogrel resistance in clopidogrel-treated Chinese patients”
por: Wang, Bin, et al.
Publicado: (2018)

Clinical Study of Clopidogrel Combined with Huoxue Tongluo Prescription in Improving Transient Ischemic Attack and the Effect on MMP-9, Hcy, and CRP
por: Ma, Lifang, et al.
Publicado: (2022)

Platelet aggregometry testing during aspirin or clopidogrel treatment and measurement of clopidogrel metabolite concentrations in dogs with protein‐losing nephropathy
por: Shropshire, Sarah, et al.
Publicado: (2020)

Comparison Between Aspirin and Clopidogrel in Secondary Stroke Prevention Based on Real‐World Data
por: Chi, Nai‐Fang, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_d1q4sph1c5kjfa05460vc93841